Group One Trading’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23
Closed -$795 8143
2025
Q3
$795 Sell
23
-186
-89% -$4.29K ﹤0.01% 8092
2025
Q2
$4.13K Sell
209
-215
-51% -$4.36K ﹤0.01% 7161
2025
Q1
$7.36K Sell
424
-98
-19% -$2.1K ﹤0.01% 6443
2024
Q4
$15.4K Buy
+522
New +$43.8K ﹤0.01% 5858
2024
Q3
Sell
-2,297
Closed -$193K 6645
2024
Q2
$157K Buy
2,297
+2,067
+899% +$246K ﹤0.01% 3598
2024
Q1
$39.5K Buy
+230
New +$28.6K ﹤0.01% 4903
2023
Q4
Sell
-493
Closed -$42.7K 7383
2023
Q3
$41.9K Buy
493
+485
+6,063% +$61.8K ﹤0.01% 5271
2023
Q2
$1.2K Sell
8
-7
-47% -$1.2K ﹤0.01% 7222
2023
Q1
$2.04K Sell
15
-12
-44% -$2.16K ﹤0.01% 6611
2022
Q4
$11.1K Buy
+27
New +$11.2K ﹤0.01% 5979
2022
Q3
Sell
-88
Closed -$28.8K 7542
2022
Q2
$13K Buy
88
+72
+450% +$11.5K ﹤0.01% 6591
2022
Q1
$4K Sell
16
-38
-70% -$15.9K ﹤0.01% 7515
2021
Q4
$53K Buy
54
+49
+980% +$62.7K ﹤0.01% 6283
2021
Q3
$8K Buy
+5
New +$9.74K ﹤0.01% 7586

Other funds holding BCAB

Group One Trading's BCAB Position: Q4 2025 in Review

Group One Trading sold out of BioAtla (BCAB) in Q4 2025, closing a stake of 23 shares — an estimated $795 sold.

Group One Trading first reported a position in BCAB in Q3 2021 and held it in 14 quarters. The position peaked at $157K in Q2 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q4 2025.

  • Group One Trading reported no remaining BioAtla position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 23 BioAtla shares in Q4 2025, an estimated $795.
  • Group One Trading first reported a position in BioAtla in Q3 2021 and held it in 14 quarters.
  • Group One Trading's BioAtla position peaked at $157K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.